Skip to content
Unrated Drug recall · FDA · Published March 5, 2020

Fresenius Medical Care: Sodium Chloride 0.9% Injection Recall Due to Sterilization Issue

Fresenius Medical Care recalls 1000mL Sodium Chloride 0.9% Injection bags with improper sterilization indicators. This may affect safety during medical use. Contact for details.

🇺🇸 FDA recall #D-1064-2020DrugFresenius Medical Care ›
Take action

Contact the company

Recalling firmFresenius Medical Care Holdings, Inc.920 Winter St Bld 950 · Waltham, MA 02451-1521
✎ GovInfoNow plain-language explainer

Fresenius Medical Care is recalling 1000 mL Sodium Chloride 0.9% Injection bags that were manufactured with a sterilization process error. This could lead to improper sterilization, potentially causing infection risks during medical use. Read more at govinfonow.com/recall/37345-fresenius-medical-care-sodium-chloride-0-9-injection-recall-due.

Source Summary by GovInfoNow · govinfonow.com/recall/37345-fresenius-medical-care-sodium-chloride-0-9-injection-recall-due · Updated October 5, 2026 · FDA enforcement record: FDA #D-1064-2020

Cite this page

“Fresenius Medical Care: Sodium Chloride 0.9% Injection Recall Due to Sterilization Issue.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37345-fresenius-medical-care-sodium-chloride-0-9-injection-recall-due. Based on FDA recall #D-1064-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1064-2020%22&limit=1).

The FDA announced on March 5, 2020, that Fresenius Medical Care Holdings, Inc. voluntarily recalled Sodium Chloride 0.9% Injection, USP, 1000 mL bags due to a cGMP deviation involving improperly positioned chemical indicators during sterilization.

How to tell if you have it

  • Brand: Fresenius Medical Care
  • Product: Sodium Chloride 0.9% Injection, USP, 1000 mL bags
  • Lot #: 19EG02012 (Exp. Date 05/2020), 19EG02019 (Exp. Date 05/2020), 19DG02050 (Exp. Date 04/2020)
  • Manufacturer: Fresenius Medical Care North America, Waltham, MA
  • Quantity: 32,592 bags

The hazard

The recall addresses a current good manufacturing practice (cGMP) deviation where chemical indicators were not positioned properly during the sterilization process.

Context

GovInfoNow's records show Fresenius Medical Care Holdings, Inc. has 44 other recalls on record since April 14, 2014. Recent recalls include a Fresenius Bicarby Dialysate leak risk reported on May 12, 2026, and a Fresenius 5008X Blood Tubing Set recall for online port errors on May 11, 2026. Other recent recalls of similar products include Fresenius Kabi Sodium Chloride Injection recalls for lack of sterility assurance on March 11, 2026.

How to tell if you have this one

Check for lot numbers 19EG02012, 19EG02019 (expiring May 2020) or 19DG02050 (expiring April 2020). These bags are for prescription use only and were manufactured by Fresenius Medical Care North America.

  • Brand
    Fresenius Medical Care
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Number

    Look for lot numbers 19EG02012, 19EG02019 (expiring May 2020) or 19DG02050 (expiring April 2020) on the bag.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed throughout the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.9 years after the firm started it.

1. Firm started the recall: Mar 5, 202012. Published in FDA’s Enforcement Report: Mar 25, 202023. FDA classified it Class II: Mar 26, 202034. FDA terminated the recall: Feb 3, 2023420202023
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class II
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1064-2020 (March 5, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1064-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA